Cytek Biosciences Inc — Balance Sheet (NASDAQ:CTKB) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 463.31 M519.48 M494.46 M499.5 M461.54 M Total liabilities 57.92 M93.93 M101.39 M103.76 M119.8 M Total equity 405.38 M425.55 M393.06 M395.74 M341.74 M Total liabilities & shareholders' equities 463.31 M519.48 M494.46 M499.5 M461.54 M Total debt ————— Net debt —————

新闻

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

Cytek Biosciences Q3 每股收益逊于预期, 营收超出预期

Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains?

Cytek Biosciences: Growth Over Profit Will Pay Off In The Long Term (NASDAQ:CTKB)